RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety-Reference-Cited by-同舟云学术

RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety

Published:2021-08 Issue: Volume:Volume 16 Page:5565-5580
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Lu Yu,Peng Zidong^ORCID,Zhu Di,Jia Yijiang,Taledaohan Ayijiang,Li Yuanming,Liu Jiawang,Wang Yanming,Wang Yuji^ORCID

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference61 articles.

1. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis

2. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination

3. ScienceDirect. Clin Microbiol Newsl. 2015;37(4):33. doi:10.1016/j.clinmicnews.2015.01.008

4. Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination

5. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-05-10

2. PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis;Advanced Science;2024-05-06

3. Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy;Pharmaceutics;2024-02-28

4. Nanotechnology in vaccines and personalized medicine;Comprehensive Precision Medicine;2024

5. Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis;Biomedicine & Pharmacotherapy;2023-12